2[2]Louie JP,Bell LM.Appropriate use of antibiotiocs for common infections in an era of increasing resistance.Emerg Med Clin North Am,2002,20:69-91.
3[3]Seppala H,Klaukka T,Vuopio-Varkila J,et al.The effect of changes in the consumption of macrolide antibiiotica on erythromycin resistance in group A streptococci in Finlang.Finnish Study Group for Antimicrobial Resistance.N Engl J Med,1997,337:441-446.
2Antibiotical therapeutic chemical (ATC) classification index with Defined daily Doses (DDDS) [J]. WHO Collaborating Centre for Drug statistics Methodology, Olso Norway, 1997.
3National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing[S]. Tenth informational supplement M100-S10.2000. 1-54.
4Louie JP, Bell LM. Appropriate use of antibiotiocs for common infections in an era of increasing resistance[J]. Emerg Med Clin North Am,2002,20:69-91.
5Seppala H, Klaukka T, Vuopio Varkila J, et al. The effect of changes in the consumption of macrolide antibiotica on crythro myein resistance in group A streptococei in Finland[J]. Finnish Study Group for Antimicrobial Resislance. N Engl J Med, 1997,337:441-446.
6Van Kerkhoven D, Pectermans WE, Verbist L, et al. Breakthrough penumococcal bacteraemin in patients treated with clarithromycin or oral beta lactams[J]. J Antimicroh Chemother, 2003,51 : 691-696.
7Song JH, Lee NY, Ichiyamas S. Spread of drug-resistanl Streptococcus pneumoniae in Asian counties: Asian network for surveillance of resistant pathogens (ANSORP) study [J].Clin Infect Dis, 1999, 28:1206-1211.
8Ariffin H, Navaratnam P, Kee TK, et al. Antibiotic resistance patterns in nosocomial gram negative bacterial infections in units with heavy antibiotic usage[J]. J Trop Pediatr,2004, 50(1) :26-17.
